Side-by-side comparison of AI visibility scores, market position, and capabilities
Chesapeake VA value retail (NASDAQ: DLTR) at $17.6B FY2024 revenue; Family Dollar sold for $1B (2025, vs. $9.5B acquired 2015), multi-price 3.0 format ($1.25-$7) in 2,900 stores competing with Dollar General for value shoppers.
Dollar Tree, Inc. is a Chesapeake, Virginia-based discount variety retailer — publicly traded on NASDAQ (NASDAQ: DLTR) as an S&P 500 Consumer Staples component — operating as a Fortune 200 company with approximately 16,000 stores across 48 states and five Canadian provinces through over 214,000 employees, with fiscal year 2024 revenue of $17.6 billion. The company's defining strategic development of 2025 was the completion of the sale of its Family Dollar business to Brigade Capital Management and Macellum Capital Management for just over $1 billion — a $8.5 billion write-down from the original $9.5 billion Family Dollar acquisition price in 2015, marking one of the largest retail acquisition failures in recent history. The divestiture concentrates Dollar Tree on its core namesake banner, which has undergone its own transformation: the company raised prices from $1.00 to $1.25 in 2022 (the first price increase in 36 years of the $1 fixed-price promise) and has expanded approximately 2,900 stores to the multi-price "3.0" format offering products up to $7. Founded in 1986 by Macon Brock and Doug Perry in Norfolk, Virginia as a single-price point variety store, Dollar Tree grew to become the dominant US single-price-point retailer before the ill-fated Family Dollar acquisition transformed it into a dual-banner company trying to serve both the $1-focused impulse buyer and the neighborhood dollar store shopper.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.